heart - Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Amarin gets FDA priority review status for Vascepa in CV indication

Amarin is seeking approval for Vascepa to decrease residual cardiovascular risk. Credit: StockSnap from Pixabay.